127 related articles for article (PubMed ID: 16810199)
21. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
Meyers S; Lenny N; Sun W; Hiebert SW
Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
[TBL] [Abstract][Full Text] [Related]
22. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.
Liu T; Jankovic D; Brault L; Ehret S; Baty F; Stavropoulou V; Rossi V; Biondi A; Schwaller J
Leukemia; 2010 Mar; 24(3):601-12. PubMed ID: 20072157
[TBL] [Abstract][Full Text] [Related]
23. Insertional mutagenesis and transformation of hematopoietic stem cells.
Ihle JN; Morishita K; Matsugi T; Bartholomew C
Prog Clin Biol Res; 1990; 352():329-37. PubMed ID: 2169632
[TBL] [Abstract][Full Text] [Related]
24. Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia.
Martini A; La Starza R; Janssen H; Bilhou-Nabera C; Corveleyn A; Somers R; Aventin A; Foà R; Hagemeijer A; Mecucci C; Marynen P
Cancer Res; 2002 Oct; 62(19):5408-12. PubMed ID: 12359745
[TBL] [Abstract][Full Text] [Related]
25. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.
Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD
Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431
[TBL] [Abstract][Full Text] [Related]
26. Extrinsic signals determine myeloid-erythroid lineage switch in MN1 leukemia.
Heuser M; Park G; Moon Y; Berg T; Xiang P; Kuchenbauer F; Vollett S; Lai C; Humphries RK
Exp Hematol; 2010 Mar; 38(3):174-9. PubMed ID: 20096329
[TBL] [Abstract][Full Text] [Related]
27. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
[TBL] [Abstract][Full Text] [Related]
28. Analysis of TEL proteins in human leukemias.
Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
[TBL] [Abstract][Full Text] [Related]
29. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes.
Schwaller J; Frantsve J; Aster J; Williams IR; Tomasson MH; Ross TS; Peeters P; Van Rompaey L; Van Etten RA; Ilaria R; Marynen P; Gilliland DG
EMBO J; 1998 Sep; 17(18):5321-33. PubMed ID: 9736611
[TBL] [Abstract][Full Text] [Related]
30. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.
Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW
Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906
[TBL] [Abstract][Full Text] [Related]
31. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
32. High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells.
Numata M; Yener MD; Ekmekçi SS; Aydın M; Grosveld G; Cardone M; Terranova S; Geltink RK; Özbek U; Özçelik E; Güleç Ç; Anak S; Karaman S; Öztürk G; Akbıyık M; Kandilci A
Leuk Res; 2015 Aug; 39(8):906-12. PubMed ID: 26111797
[TBL] [Abstract][Full Text] [Related]
33. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.
Cozzio A; Passegué E; Ayton PM; Karsunky H; Cleary ML; Weissman IL
Genes Dev; 2003 Dec; 17(24):3029-35. PubMed ID: 14701873
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of TEL-MN1 Fusion Enhances Resistance of HL-60 Cells to Idarubicin.
Gong S; Guo M; Tang G; Yang J; Qiu H
Chemotherapy; 2018; 63(6):308-314. PubMed ID: 30840968
[TBL] [Abstract][Full Text] [Related]
35. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.
Lavau C; Szilvassy SJ; Slany R; Cleary ML
EMBO J; 1997 Jul; 16(14):4226-37. PubMed ID: 9250666
[TBL] [Abstract][Full Text] [Related]
36. Directing oncogenic fusion genes into stem cells via an SCL enhancer.
Eguchi M; Eguchi-Ishimae M; Green A; Enver T; Greaves M
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1133-8. PubMed ID: 15650051
[TBL] [Abstract][Full Text] [Related]
37. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity.
Morrow M; Horton S; Kioussis D; Brady HJ; Williams O
Blood; 2004 May; 103(10):3890-6. PubMed ID: 14726384
[TBL] [Abstract][Full Text] [Related]
38. [Molecular cytogenetic characterization of five patients with myeloid leukemia and t(12;22)(p13;q12)].
Shao H; Yang Q; Gong Y; Bai S; Zhang J; Wang Y; Shen J; Wu C; Qiu H; Chen S; Pan J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Feb; 36(2):112-115. PubMed ID: 30703225
[TBL] [Abstract][Full Text] [Related]
39. Two unbalanced translocations, t(12;22)(p13;q11) and t(12;?)(p13;?), in an aggressive chronic B-cell leukemia: TEL gene analysis using FISH.
Conchon M; McManus AP; Min T; Maljaie SH; Crawford A; Brito-Babapulle V; Matutes E; Catovsky D
Cancer Genet Cytogenet; 1997 Jun; 95(2):137-40. PubMed ID: 9169030
[TBL] [Abstract][Full Text] [Related]
40. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice.
Kamps MP; Baltimore D
Mol Cell Biol; 1993 Jan; 13(1):351-7. PubMed ID: 8093327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
